SMAD3 and myocardial infarction: In a myocardial infarction (MI) model, deletion of Smad3 in cardiomyocytes protects against MI by suppressing apoptosis and attenuating adverse remodeling (260), whereas its deletion in fibroblasts or macrophages promotes MI pathogenesis (260, 261).